Urinary lysophopholipids are increased in diabetic patients with nephropathy.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of diabetes and its complications"
DOI: 10.1016/j.jdiacomp.2017.04.024
Abstract: Diabetic nephropathy (DN) is a major cause of chronic kidney disease that frequently leads to end stage renal failure. Lysophosphatidic acid (LPA) and lysophosphatidylcholine (LPC) are lysophospholipid mediators shown to accumulate in kidney and to… read more here.
Keywords: diabetic patients; lpa lpc; cases controls; kidney ... See more keywords